AzTrials
AzTrials

White Spot LesionNCT05001035

Effect of Different Biomimetic Materials on White Spot Lesions in Enamel

A study testing Time of assessment in people with White Spot Lesion, run by Benha University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will be conducted to evaluate: 1- The remineralizing effect of different biomimetic materials (Zinc carbonate hydroxyapatite nanoparticles, Poly-amido amine (PAMAM) and bioactive glass nanoparticles) on white spot lesions in enamel. Read more about this study

Who is it for?
Ages 15 to 25 yearsHealthy volunteers can take part
Conditions the study is for
White Spot Lesion
What is being tested?
Time of assessment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteEgypt
Study dates
1 Jul 2021to 20 Sep 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Total of 21 patients enrolled in this study will be selected having at least 4 teeth (one on each quadrant) which will be extracted for orthodontic treatment.
  • These patients will be selected according to age groups between 15-25 years old
  • good oral hygiene
  • free of destroying habits for dental tissues

Who cannot join

  • Bruxism
  • soft drinks consumption
  • acid regurgitation, etc.).
  • Selected teeth having any cracks, malformations, dysplasia or caries.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of dental medicine for girls branch of Alazhar University

    Cairo

Other trials in Egypt

About this study

This study will be conducted to evaluate: 1- The remineralizing effect of different biomimetic materials (Zinc carbonate hydroxyapatite nanoparticles, Poly-amido amine (PAMAM) and bioactive glass nanoparticles) on white spot lesions in enamel. 2- The clinical efficacy of these agents on disappearance of these white spots.

Being tested
Time of assessment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Time of assessmentOther

    Immediate and after one month and after two months

Study groups in NCT05001035
Study groupRoleWhat they receive
Zinc carbonated hydroxy apatiteExperimentalToothpaste to be added on white spot lesions in dental enamel
Receives: Other: Time of assessment
Bioactive glassExperimentalToothpaste to be added on white spot lesions in dental enamel
Receives: Other: Time of assessment
Poly amido amineExperimentalResinous material to be painted on white spot lesions in dental enamel
Receives: Other: Time of assessment
ControlNo interventionNo material to be added

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in remineralization from base line to time limit

    Change in its density in digital xray

    Measured: Immediate and one month and two months

  2. changes of appearance from base line photograph to time limit

    White spots disappear on digital photography

    Measured: Immediate and one month and two months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2021
  2. Study start1 Jul 2021
  3. Primary completion18 Sep 2021
  4. Study completion20 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Split mouth technique
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05001035
Sponsor's protocol ID
OP-P-018-001
Other IDs
OPDEN-107-1-G
Status last verified
Oct 2021
First submitted
28 Jul 2021
Last updated
7 Oct 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Time of assessment in people with White Spot Lesion, run by Benha University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in remineralization from base line to time limit (time frame: Immediate and one month and two months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in